ADAP Advocacy Association CEO: 340B program ‘has morphed into a cash cow for big hospital systems and mega service providers’
Brandon Macsata, CEO of the ADAP Advocacy Association, has raised concerns about the 340B Drug Pricing Program, suggesting it has deviated from its original purpose.






